Similar Items: Molecular analysis of decay accelerating factor as a potential susceptibility factor to developing treatment resistant extraocular muscle involvement in Myasthenia Gravis
- Treatment-resistant ophthalmoplegia in Myasthenia gravis: extraocular muscle pathology, the role of TGFβ1 and the derivation of induced pluripotency towards 'disease-in-a-dish' modeling
- Identifying the molecular basis for treatment resistance in a subset of myasthenia gravis patients of African ancestory
- Myasthenia Gravis: A Nursing Perspective
- Treatment-resistant ophthalmoplegia in myasthenia gravis: Clinical, molecular and functional studies of patient-derived orbital tissues
- Investigating the functionality of candidate susceptibility genes in ophthalmoplegic myasthenia gravis using patient-derived material
- Predictive Factors for Non-response to First Use of Polyvalent Intravenous Immunoglobulin in Generalised Myasthenia Gravis
Author: Heckmann, Jeannine
- Distal sensory polyneuropathy in South Africans infected with human immunodeficiency virus : a cross-sectional analysis of a community cohort
- Distal sensory polyneuropathy in HIV/TB co-infection : the role of vitamin B6 and N-acetyltransferase 2 genetic variation
- Subacute measles encephalitis: The neurological sequelae of the measles outbreak in South Africa
- Neuropsychiatric symptoms in thymoma-associated and non-thymoma myasthenia gravis
- Molecular analysis of decay accelerating factor as a potential susceptibility factor to developing treatment resistant extraocular muscle involvement in Myasthenia Gravis
- Identifying the molecular basis for treatment resistance in a subset of myasthenia gravis patients of African ancestory